Neuronetics (STIM) Shareholder's Equity (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.45% |
| Dec 31, 2025 | -4.08% |
| Sep 30, 2025 | -13.17% |
| Jun 30, 2025 | -20.30% |
| Mar 31, 2025 | 24.32% |
| Dec 31, 2024 | 238.97% |
| Sep 30, 2024 | -51.61% |
| Jun 30, 2024 | -29.90% |
| Mar 31, 2024 | -19.11% |
| Dec 31, 2023 | -9.89% |
| Sep 30, 2023 | -16.57% |
| Jun 30, 2023 | -5.93% |
| Mar 31, 2023 | -15.27% |
| Dec 31, 2022 | -9.42% |
| Sep 30, 2022 | -7.94% |
| Jun 30, 2022 | -10.67% |
| Mar 31, 2022 | -10.07% |
| Dec 31, 2021 | -6.48% |
| Sep 30, 2021 | -6.27% |
| Jun 30, 2021 | -4.71% |
| Mar 31, 2021 | 300.00% |
| Dec 31, 2020 | -7.22% |
| Sep 30, 2020 | -6.66% |
| Jun 30, 2020 | -19.37% |
| Mar 31, 2020 | -23.70% |
| Dec 31, 2019 | -11.92% |
| Sep 30, 2019 | -9.18% |
| Jun 30, 2019 | -8.56% |
| Mar 31, 2019 | -7.91% |
| Dec 31, 2018 | -6.95% |
| Sep 30, 2018 | 137.19% |
| Jun 30, 2018 | -3.69% |
| Mar 31, 2018 | -2.76% |